Literature DB >> 23974912

[Neutropenia and sepsis].

M Kochanek1, B Böll, M Hallek, M von Bergwelt-Baildon.   

Abstract

The clinical management of neutropenic infections represents a great diagnostic and therapeutic challenge. Established sepsis criteria only partially reflect the neutropenic setting. Diagnostic procedures are frequently impaired by thrombocytopenia and progressive respiratory insufficiency. Increased tendency to bleed, engraftment, and fulminant progression represent major therapeutic challenges. Thus, crucial for the diagnosis and therapy of neutropenic sepsis are clear and well-communicated algorithms, rapid action, and close collaboration between oncologists and intensivists.

Entities:  

Mesh:

Year:  2013        PMID: 23974912     DOI: 10.1007/s00108-013-3258-z

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  36 in total

Review 1.  Human recombinant activated protein C for severe sepsis.

Authors:  Arturo J Martí-Carvajal; Ivan Solà; Dimitrios Lathyris; Andrés Felipe Cardona
Journal:  Cochrane Database Syst Rev       Date:  2011-04-13

2.  In situ diagnosis of intravascular catheter-related bloodstream infection: a comparison of quantitative culture, differential time to positivity, and endoluminal brushing.

Authors:  James A Catton; Brian M Dobbins; Peter Kite; Jonathan M Wood; Kerrie Eastwood; Sarah Sugden; Jonathon A T Sandoe; Dermot Burke; Michael J McMahon; Mark H Wilcox
Journal:  Crit Care Med       Date:  2005-04       Impact factor: 7.598

3.  Central line-associated bloodstream infections in adult hematology patients with febrile neutropenia: an evaluation of surveillance definitions using differential time to blood culture positivity.

Authors:  Joshua T Freeman; Anna Elinder-Camburn; Catherine McClymont; Deverick J Anderson; Mary Bilkey; Deborah A Williamson; Leanne Berkahn; Sally A Roberts
Journal:  Infect Control Hosp Epidemiol       Date:  2012-11-20       Impact factor: 3.254

4.  CCC meets ICU: redefining the role of critical care of cancer patients.

Authors:  Michael von Bergwelt-Baildon; Michael J Hallek; Alexander A Shimabukuro-Vornhagen; Matthias Kochanek
Journal:  BMC Cancer       Date:  2010-11-08       Impact factor: 4.430

Review 5.  Diagnosis and management of infectious complications in critically ill patients with cancer.

Authors:  Raghukumar Thirumala; Madhusudanan Ramaswamy; Sanjay Chawla
Journal:  Crit Care Clin       Date:  2010-01       Impact factor: 3.598

6.  Noninvasive ventilation for the treatment of acute respiratory failure in patients with hematologic malignancies: a pilot study.

Authors:  G Conti; P Marino; A Cogliati; D Dell'Utri; A Lappa; G Rosa; A Gasparetto
Journal:  Intensive Care Med       Date:  1998-12       Impact factor: 17.440

7.  Impact of recent intravenous chemotherapy on outcome in severe sepsis and septic shock patients with hematological malignancies.

Authors:  Dominique M Vandijck; Dominique D Benoit; Pieter O Depuydt; Fritz C Offner; Stijn I Blot; Anna K Van Tilborgh; Joke Nollet; Eva Steel; Lucien A Noens; Johan M Decruyenaere
Journal:  Intensive Care Med       Date:  2008-01-24       Impact factor: 17.440

Review 8.  Bloodstream infections in cancer patients with febrile neutropenia.

Authors:  Ronald Feld
Journal:  Int J Antimicrob Agents       Date:  2008-09-07       Impact factor: 5.283

9.  Unfractioned heparin for treatment of sepsis: A randomized clinical trial (The HETRASE Study).

Authors:  Fabián Jaimes; Gisela De La Rosa; Carlos Morales; Fernando Fortich; Clara Arango; Daniel Aguirre; Alvaro Muñoz
Journal:  Crit Care Med       Date:  2009-04       Impact factor: 7.598

Review 10.  Prophylactic antibiotics or G-CSF for the prevention of infections and improvement of survival in cancer patients undergoing chemotherapy.

Authors:  Christine Herbst; Frauke Naumann; Eva-Brigitta Kruse; Ina Monsef; Julia Bohlius; Holger Schulz; Andreas Engert
Journal:  Cochrane Database Syst Rev       Date:  2009-01-21
View more
  1 in total

1.  [Mortality of hematology-oncology patients with neutropenia in intensivecare].

Authors:  I Suárez; B Böll; A Shimabukuro-Vornhagen; G Michels; M von Bergwelt-Baildon; M Kochanek
Journal:  Med Klin Intensivmed Notfmed       Date:  2015-05-21       Impact factor: 0.840

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.